UNC-CA359

Modify Date: 2025-08-30 00:09:00

UNC-CA359 Structure
UNC-CA359 structure
Common Name UNC-CA359
CAS Number 2676156-05-9 Molecular Weight 339.78
Density N/A Boiling Point N/A
Molecular Formula C18H14ClN3O2 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of UNC-CA359


UNC-CA359 is a potent epidermal growth factor receptor (EGFR) inhibitor, with an IC50 value of 18 nM. UNC-CA359 exhibits strong anti-tumor activity, can be used to Chordoma research[1].

 Names

Name UNC-CA359

 UNC-CA359 Biological Activity

Description UNC-CA359 is a potent epidermal growth factor receptor (EGFR) inhibitor, with an IC50 value of 18 nM. UNC-CA359 exhibits strong anti-tumor activity, can be used to Chordoma research[1].
Related Catalog
Target

IC50: 18 nM (EGFR)[1]

In Vitro UNC-CA359 (compound 45) loses activity on U-CH1, leaves some activity on U-CH2, and maintains inhibition on EGFR, with IC50s of >100 μM, 35 μM, and 18 nM, respectively[1]. UNC-CA359 (1 nM-0.1 mM; 72 h) has activity against chordoma with IC50s of 1.2 μM (CH22), and 3.0 μM (U-CH12), respectively[1]. UNC-CA359 shows UNC-CA359 (compound 102) has three main collateral kinase targets, and shows high potency towards SLK/STK10 with a promising selectivity ratio (NAK over SLK/STK10) of 22, while the binding constant Ki values are 3.4 nM (GAK), 0.33 μM (SLK), 0.075 μM (STK10), respectively[2]. GAK: cyclin G associated kinase; SLK: STE20-like serine/threonine-protein kinase; STK10: serine/threonine-protein kinase 10. Cell Cytotoxicity Assay[1] Cell Line: Chordoma cell lines: CH22, UM-Chor1, U-CH12 and U-CH7; WS1 Concentration: 1 nM-100 μM Incubation Time: 72 hours Result: Demonstrated good potential against chordoma cells, with IC50s of 1.2 μM (CH22), 3.0 μM (U-CH12), 60 μM (UM-Chor1), 74 μM (U-CH7), respectively. Showed no toxicity towards WS1 cell (IC50 >100 μM).
References

[1]. Bieberich AA, et al. Optimization of the 4-anilinoquin(az)oline scaffold as epidermal growth factor receptor (EGFR) inhibitors for chordoma utilizing a toxicology profiling assay platform. Sci Rep. 2022 Jul 27. 12(1):12820.

[2]. Asquith CRM, et al. Design and Analysis of the 4-Anilinoquin(az)oline Kinase Inhibition Profiles of GAK/SLK/STK10 Using Quantitative Structure-Activity Relationships. ChemMedChem. 2020 Jan 7. 15(1):26-49.

 Chemical & Physical Properties

Molecular Formula C18H14ClN3O2
Molecular Weight 339.78
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.